Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

Article English OPEN
Di Pierro F; Villanova N; Agostini F; Marzocchi R; Soverini V; Marchesini G;
(2012)
  • Publisher: Dove Medical Press
  • Journal: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, volume 5, pages 213-217 (issn: 1178-7007, eissn: 1178-7007)
  • Publisher copyright policies & self-archiving
  • Identifiers: pmc: PMC3422905, doi: 10.2147/DMSO.S33718
  • Subject: silymarin | RC581-951 | Targets and Therapy [Diabetes, Metabolic Syndrome and Obesity] | Short Report | glycosylated hemoglobin | diabetes | Specialties of internal medicine | berberine

Francesco Di Pierro,1 Nicola Villanova,2 Federica Agostini,2 Rebecca Marzocchi,2 Valentina Soverini,2 Giulio Marchesini21Scientific Department, Velleja Research, Milano, 2Diseases of Metabolism, S Orsola Malpighi Hospital, Bologna, ItalyBackground: Suboptimal glycemic c... View more
  • References (25)
    25 references, page 1 of 3

    1. Shamseddeen H, Getty JZ, Hamdallah IN, Ali MR. Epidemiology and economic impact of obesity and type 2 diabetes. Surg Clin North Am. 2011;91(6):1163-1172, vii.

    2. Donner T, Muñoz M. Update on insulin therapy for type 2 diabetes. J Clin Endocrinol Metab. March 22, 2012.

    3. Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin. 2009;25(6):1413-1420.

    4. [No authors listed]. Berberine. Altern Med Rev. 2000;5(2):175-177.

    5. Vuddanda PR, Chakraborty S, Singh S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs. 2010;19(10):1297-1307.

    6. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10(12):1344-1351.

    7. Hu Y, Davies GE. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia. 2010;81(5):358-366.

    8. Kong WJ, Wei J, Zuo ZY, et al. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metabolism. 2008;57(8): 1029-1037.

    9. Cameron J, Ranheim T, Kulseth MA, Leren TP, Berge KE. Berberine decreases PCSK9 expression in HepG2 cells. Atherosclerosis. 2008;201(2):266-273.

    10. Affuso F, Ruvolo A, Micillo F, Saccà L, Fazio S. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis. 2010;20(9): 656-661.

  • Metrics
Share - Bookmark